-
Study aim
-
The results of this study can be used as a simple and available treatment for congenital lacrimal duct obstruction disease, which is one of the most common complaints in infants referred to ophthalmology.
-
Design
-
Clinical trial without control group, Community-based and pragmatic , parallel groups, no-blinding, no-random, phase 2_3 on 30 patients
-
Settings and conduct
-
Babies will be examined by a pediatrician in Jiroft and then referred to the ophthalmologist. First, the objectives of the research will be explained to the parents of the babies, and if they are willing to participate in the study and obtain informed consent, the data will be collected. In the first group, including academic treatment, eye drops and antibiotics, will be placed in the eye every six hours, and follow-up examinations will be continued every two weeks to one month and then monthly until the tear duct opens. In the second group, breast milk will be dripped into the eyes of the baby every six hours, and the follow-up examinations will be the same as the first group.
-
Participants/Inclusion and exclusion criteria
-
Babies with lacrimal duct obstruction who did not undergo any treatment after two weeks or no other diagnosis was considered for them and babies who were breastfed. Exclusion criteria will be age older than 11 months, performing other treatment methods such as probe, causing doctoriocystitis or diagnosis of other eye diseases.
-
Intervention groups
-
People who enter the study will be randomly divided into 2 groups. In the first group, academic treatment, eye drops and antibiotics will be dripped into the baby's eyes, and in the second group, breast milk will be dripped into the baby's eyes.
-
Main outcome variables
-
Inflammation, redness and obstruction